RecruitingNCT02664831

Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)

Immunoinflammatory and Metabolic Responses in Post Cardiac Arrest Syndrome (PCAS)


Sponsor

MaineHealth

Enrollment

400 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces changes in the numbers and properties of circulating immune cells, shifting the balance towards a pro-inflammatory phenotype and there is increased interest in the inflammatory pathways and the signaling mechanisms through which they are modulated. Participants will undergo blood sampling during 7 days following cardiac arrest, and analyses performed. Patient characteristics, clinical circumstances, and outcomes will be recorded and their associations with these inflammatory pathways characterized.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Aged 18 years or older
  • Admitted to the intensive care unit after cardiac arrest episode
  • Unresponsive after resuscitation

Exclusion Criteria3

  • Moribund / actively dying at the time of evaluation
  • Informed consent cannot be obtained within 24 hours of resuscitation
  • Hemoglobin less than 7.0 g/dL, active high-volume bleeding, or requiring a transfusion

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Maine Medical Center

Portland, Maine, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02664831


Related Trials